In this study, our studies describe a possible mechanism, at least in part, underlying these oncogenic functions of PRMT5; the symmetric dimethylation of 53BP1 by PRMT5 results in stabilization of its protein level and promotion of NHEJ efficiency in cancer cells. The gene discussed is PRMT5; the disease is cancer.